funder-graph

FundersCTAlliance for Cancer Gene Therapy Inc › 2024

Grants paid by Alliance for Cancer Gene Therapy Inc, tax year 2024

EIN 06-1619523 · Stamford, CT · Form 990, Schedule I · NTEE T30

In tax year 2024, Alliance for Cancer Gene Therapy Inc (EIN 06-1619523) reported 5 grants paid totaling $1,025,423. Dataset version 2026.09.0, built 2026-09-03.

20212022202320242025

Every grant, 2024

Grants reported by Alliance for Cancer Gene Therapy Inc for tax year 2024
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Chiocca Beckman Rsrch Somerville, MAA$500,000paidCANCER RESEARCH202510569349301021
2024Mackall Stamford Redwood City, CAA$500,000paidCANCER RESEARCH202510569349301021
2024Fueyo Univ of Texas Houston, TXA$13,406paidCANCER RESEARCH202510569349301021
2024Zureikat Univ of Pitts Pittsburgh, PAA$6,009paidCANCER RESEARCH202510569349301021
2024Okada Univ of Ca San Fran, CAA$6,008paidCANCER RESEARCH202510569349301021

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.